BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 9753848)

  • 1. Antiarrhythmic trials: a decade of growth.
    Kanjwal MY
    Indian Heart J; 1998; 50(3):277-84. PubMed ID: 9753848
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of electrophysiology in the prognosis and therapy of cardiomyopathies].
    Laurenzi F; Avella A; Adinolfi E; Dini P
    G Ital Cardiol; 1999 Oct; 29(10):1190-4. PubMed ID: 10546132
    [No Abstract]   [Full Text] [Related]  

  • 3. Randomized clinical trials: how long should they last?
    Wellens HJ
    Circulation; 2004 Jul; 110(2):107-8. PubMed ID: 15249514
    [No Abstract]   [Full Text] [Related]  

  • 4. A history of heart failure predicts arrhythmia treatment efficacy: data from the Antiarrythmics versus Implantable Defibrillators (AVID) study.
    Brodsky MA; McAnulty J; Zipes DP; Baessler C; Hallstrom AP;
    Am Heart J; 2006 Oct; 152(4):724-30. PubMed ID: 16996848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiodarone and mortality in CHF and post-MI.
    Zamorski M
    J Fam Pract; 1998 Mar; 46(3):196-7. PubMed ID: 9519009
    [No Abstract]   [Full Text] [Related]  

  • 6. Individual patterns of dynamic QT/RR relationship in survivors of acute myocardial infarction and their relationship to antiarrhythmic efficacy of amiodarone.
    Smetana P; Pueyo E; Hnatkova K; Batchvarov V; Laguna P; Malik M
    J Cardiovasc Electrophysiol; 2004 Oct; 15(10):1147-54. PubMed ID: 15485438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amiodarone in high-risk post-infarction patients, Lessons from EMIAT and CAMIAT. European Myocardial Infarct Amiodarone Trial and Canadian Amiodarone Myocardial Infarction Arrhythmia Trial.
    Gambhir DS
    Indian Heart J; 1996; 48(4):339-41. PubMed ID: 8908817
    [No Abstract]   [Full Text] [Related]  

  • 8. [Death is still a death. Does it matter if the cause is myocardial infarction or arrhythmia?].
    Werkö L
    Lakartidningen; 1998 Jan; 95(4):246-8. PubMed ID: 9469947
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ventricular arrhythmias after myocardial infarction: risk classification and treatment concepts].
    Seidl K; Hauer B; Schwick N; Buechele T; Schilling I; Senges J
    Dtsch Med Wochenschr; 1995 May; 120(18):656-60. PubMed ID: 7750434
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter defibrillators.
    Ho AT; Pai SM; Timothy P; Pai RG
    Pacing Clin Electrophysiol; 2005 Jul; 28(7):647-53. PubMed ID: 16008799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardiac defibrillators.
    Spivack C
    N Engl J Med; 2002 Aug; 347(5):365-7; author reply 365-7. PubMed ID: 12154817
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiarrhythmic therapy in heart failure.
    Eckardt L; Haverkamp W; Breithardt G
    Heart Fail Monit; 2002; 2(4):110-9. PubMed ID: 12634885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of therapeutic modalities in patients with life threatening arrhythmias.
    Teo KK
    Can J Cardiol; 1994 Apr; 10(3):333-8. PubMed ID: 8162531
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of antiarrhythmic agents after myocardial infarction with special reference to the EMIAT and CAMIAT trials of amiodarone. European Myocardial Infarct Amiodarone Trial. Canadian Amiodarone Myocardial Infarction Trial.
    Jafri SM; Borzak S; Goldberger J; Gheorghiade M
    Prog Cardiovasc Dis; 1998; 41(1):65-70. PubMed ID: 9717860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential impact of antiarrhythmic drugs versus implantable defibrillators on the management of ventricular arrhythmias: the Midlands trial of empirical amiodarone versus electrophysiologically guided intervention and cardioverter implant registry data.
    Pathmanathan RK; Lau EW; Cooper J; Newton L; Skehan JD; Garratt CJ; Griffith MJ
    Heart; 1998 Jul; 80(1):68-70. PubMed ID: 9764063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone: a late comer.
    Futterman LG; Lemberg L
    Am J Crit Care; 1997 May; 6(3):233-9. PubMed ID: 9131203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of patients with sustained ventricular arrhythmia: anti-arrhythmia agents or defibrillator?].
    Cappato R; Kuck KH
    Cardiologia; 1996 Feb; 41(2):95-105. PubMed ID: 8674097
    [No Abstract]   [Full Text] [Related]  

  • 18. Implantable defibrillators and/or amiodarone: alternatives or complementary therapies.
    Dorian P; Newman D; Greene M
    Int J Clin Pract; 1998 Sep; 52(6):425-8. PubMed ID: 9894382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a role for amiodarone in the era of the implantable cardioverter-defibrillator?
    Eckardt L; Breithardt G
    Heart Rhythm; 2006 Apr; 3(4):484-7. PubMed ID: 16567301
    [No Abstract]   [Full Text] [Related]  

  • 20. [Management of arrhythmias in patients with heart failure].
    Le Heuzey JY; Copie X; Piot O; Lavergne T; Henry P; Guize L
    Arch Mal Coeur Vaiss; 1998 Nov; 91(11):1371-6. PubMed ID: 9864606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.